Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;43(7):4107-4124.
doi: 10.1007/s10072-022-06068-x. Epub 2022 Apr 23.

Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline

Rossana Botto  1   2 , Nicoletta Callai  3 , Aurora Cermelli  4 , Lorenzo Causarano  5 , Innocenzo Rainero  4
Affiliations

Anxiety and depression in Alzheimer's disease: a systematic review of pathogenetic mechanisms and relation to cognitive decline

Rossana Botto et al. Neurol Sci. 2022 Jul.

Abstract

Objectives: To explore the pathogenetic hypothesis provided to explain the comorbidity of anxious and depressive symptomatology and AD and to assess the association between anxious and depressive symptoms and the AD-related cognitive impairment.

Methods: In October 2020 and March 2021, PsycINFO, Embase, Ovid, and CINAHL were searched for peer-reviewed original articles investigating anxiety and/or depression in AD.

Results: A total of 14,760 studies were identified and 34 papers on AD patients were included in the review. Suggested biological causes of depression and anxiety in AD include higher strychnine-sensitive glycine receptor (GlyRS) functioning and selective reduction of N-methyl-D-aspartate (NMDA) receptor NR2A density, cortical and limbic atrophy, lower resting cortical metabolism, lower CSF Aβ42 and higher t-tau and p-tau levels, and neuritic plaques. At the same time, dysthymia arises in the early stages of AD as an emotional reaction to the progressive cognitive decline and can cause it; anxiety can appear as an initial compensating behaviour; and depression might be related to AD awareness and loss of functional abilities. Affective symptoms and the expression of the depressive symptoms tend to reduce as AD progresses.

Conclusion: The neurodegeneration of areas and circuits dealing with emotions can elicit anxiety and depression in AD. In the early stages of the disease, anxiety and depression could arise as a psychological reaction to AD and due to coping difficulties. In late AD stages, the cognitive impairment reduces the emotional responses and their expression. Anxiety and depression are more intense in early-onset AD, due to the major impact of AD on the individual.

Keywords: Alzheimer’s disease; Anxiety; Dementia; Depression; Psychological symptoms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Causal factors for anxiety and depression in AD
Fig. 2
Fig. 2
Relationships between anxiety, depression, AD, and cognitive impairment
See this image and copyright information in PMC

References

    1. Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H. Defeating Alzheimer’s disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(5):455–532. doi: 10.1016/S1474-4422(16)00062-4. - DOI - PubMed
    1. Alzheimer’s Association. Alzheimer’s Association Report (2016) Alzheimer’s disease facts and figures. Alzheimer’s & Dementia 459-509. 10.1016/j.jalz.2016.03.001 - PubMed
    1. Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614–629. doi: 10.1016/S1474-4422(14)70090-0. - DOI - PubMed
    1. Suárez-González A, Crutch SJ, Franco-Macías E, Gil-Néciga E. Neuropsychiatric symptoms in posterior cortical atrophy and Alzheimer disease. J Geriatr Psychiatry Neurol. 2016;29(2):65–71. doi: 10.1177/0891988715606229. - DOI - PMC - PubMed
    1. Connors MH, Seeher KM, Crawford J, Ames D, Woodward M, Brodaty H. The stability of neuropsychiatric subsyndromes in Alzheimer’s disease. Alzheimers Dement. 2018;14(7):880–888. doi: 10.1016/j.jalz.2018.02.006. - DOI - PubMed

Publication types